Daiichi Sankyo UK Limited

Chiltern Place, Chalfont Park, Gerrards Cross, Buckinghamshire, SL9 0BG, UK
Telephone: +44 (0)1753 482 771
Medical Information Direct Line: +44 (0)1753 482 771
Medical Information e-mail: medinfo@daiichi-sankyo.co.uk
Customer Care direct line: +44 (0)1753 482 771
Medical Information Fax: +44 (0)1753 893 894
Out of Hours Telephone: +44 (0)1748 828 818

Patient Information Leaflet last updated on the eMC: 26/09/2008
PIL Evista 60mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 26/09/2008 and displayed until Current
Reasons for adding or updating:
  • Change of licence holder
Updated on 15/05/2007 and displayed until 26/09/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 10/01/2007 and displayed until 15/05/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 09/05/2006 and displayed until 10/01/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 23/09/2003 and displayed until 09/05/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 30/04/2003 and displayed until 23/09/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 11/03/2002 and displayed until 30/04/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 14/06/2000 and displayed until 11/03/2002
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   raloxifene